Spore.Bio raised $23M in a Series A round led by Singular to enhance microbiology testing with machine learning.
Spore.Bio raised $23M in a Series A round led by Singular to enhance microbiology testing with machine learning.
02/20/25, 5:23 AM
Location
parisMoney raised
$23 million
Industry
manufacturing
Round Type
series a
Investors
Famille C, No Label Ventures, Local Globe, Lord David Prior, Station F, 1st Kind Ventures, Point 72 Ventures, Singular
Spore.Bio, a Paris-based deeptech startup, has secured $23 million in a Series A funding round. The company aims to revolutionize microbiology testing in the food industry to prevent contamination crises and has already garnered significant customer interest.